Brief: Arca Biopharma Announces First Quarter 2022 Financial Results
02/05/2022 21:53
May 2 (Reuters) - ARCA Biopharma Inc ABIO.O :
* ARCA BIOPHARMA ANNOUNCES FIRST QUARTER 2022 FINANCIAL
RESULTS
* Q1 LOSS PER SHARE $0.23
* ARCA BIOPHARMA - BELIEVES CASH AND CASH EQUIVALENTS
SUFFICIENT
TO FUND OPERATIONS AT CURRENT LEVELS THROUGH AT LEAST MIDDLE OF
2023
Source text for Eikon: ID:nGNX79w0yl
Further company coverage: ABIO.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Oruka Therapeutics
See all newsOruka falls after reporting mid-stage data for psoriasis drug
Brief: Oruka Therapeutics Announces Positive Week 28 Data For Orka-001 From The Ongoing Everlast-A Trial Showing Deepening Of Responses Without Additional Dosing
Brief: Oruka Therapeutics Appoints Todd Edwards As Chief Commercial Officer
U.S. RESEARCH ROUNDUP-Accendra Health, Celestica, Sionna Therapeutics
Oruka Therapeutics Inc reports results for the quarter ended June 30 - Earnings Summary